Cytek Biosciences

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

Display,Of,Stock,Market,Quotes

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

CODI

CTKB

DXYZ

GLXY

IONQ

OKTA

DHT Holdings Posts Weak Sales, Joins Compass Diversified, Okta And Other Big Stocks Moving Lower In Wednesday&#39;s Pre-Market Session

Wall-Street-ai7-1

Eurozone

Commodities

Intraday Update

EVTL

HSAI

TRAW

Nasdaq Down Over 100 Points; US Pending Home Sales Increase In November

Crude-oil-4-logo

Earnings

Equities

QMCO

Crude Oil Gains 1%; Chicago PMI Falls In December

Cytek Biosciences Inc

Press Releases

Cytek Biosciences Announces Preliminary Full Year 2024 Revenue Results

Health Care

Cytek Biosciences to Participate in Upcoming Investor Conferences

Cytek Biosciences to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025

Cytek Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Outlook

General

Cytek® Biosciences Expands Cell Analysis Offerings with the Affordable, User-Friendly Cytek® Muse® Micro System

Cytek Biosciences to Report First Quarter 2025 Financial Results on May 8, 2025

Cytek® Biosciences Brings Cutting-Edge Cell Analysis Solutions to CYTO and IMMUNOLOGY2025

Cytek Biosciences Reports First Quarter 2025 Financial Results

Cytek Biosciences to participate at the Goldman Sachs 46th Annual Global Healthcare Conference

Cytek® Biosciences Is Setting the New Standard for Full Spectrum Flow Cytometry with the New Cytek Aurora™ Evo Flow Cytometer

AbCellera Biologics

Adaptive Biotechnologies Corporation - Common Stock

Adaptive Biotechnologies

Atlantic International Corp. - Common Stock

Atlantic International

Azenta

BioLife Solutions

Bruker

Codexis

CryoPort

Evotec SE - American Depositary Shares each representing 1/2 of one ordinary share

Evotec

Fortrea Holdings

Standard BioTools

Lifecore Biomedical

Mesa Laboratories

Maravai LifeSciences Holdings, Inc. - Class A common stock

Maravai LifeSciences

MaxCyte

Niagen Bioscience

OmniAb

Pacific Biosciences of California, Inc. - Common Stock

Pacific Biosciences

Personalis

Quantum-Si Incorporated - Class A Common Stock

Quantum-Si

Quanterix

Rapid Micro Biosystems, Inc. - Class A Common Stock

Rapid Micro Biosystems

Sotera Health

Alpha Teknova

10x Genomics

Morgan Stanley

Goldman Sachs

Stephens & Co.

Piper Sandler

Comments

Cytek Biosciences

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell